Date:2/3/2009

ease to cancer. Based upon these discoveries deCODE has brought to market a growing range of DNA-based tests for gauging risk and empowering prevention of common diseases. Through its CLIA-registered laboratory, deCODE is offers deCODE T2(TM) for type 2 diabetes; deCODE AF(TM) for atrial fibrillation and stroke; deCODE MI(TM) for heart attack; deCODE ProstateCancer(TM) for prostate cancer; deCODE Glaucoma(TM) for a major type of glaucoma; and deCODE BreastCancer(TM), for the common forms of breast cancer. deCODE is delivering on the promise of the new genetics.(SM) Visit us on the web at http://www.decode.com; on our diagnostics site at http://www.decodediagnostics.com; for our pioneering personal genome analysis service and new Cardio and Cancer scans, integrating the genetic variants included in these tests and those linked to another twenty common diseases, at http://www.decodeme.com; and on our blog at http://www.decodeyou.com.

Any statements contained in this presentation that relate to future plans, events or performance are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results, and the timing of events, to differ materially from those described in the forward-looking statements. These risks and uncertainties include, among others, those relating to our ability to obtain financing and to form collaborative relationships, the effect of a potential delisting of our common stock from The Nasdaq Global Market, our ability to develop and market diagnostic products, the level of third party reimbursement for our products, risks related to preclinical and cl
'/>"/>

SOURCE deCODE genetics Inc Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5
Related medicine news :

1. New Web-Based User Self Service & Identity Management Software for Active Directory takes Security, User Convenience to a Whole New Level
2. Test Your Vitamin D Knowledge: Wellesse Liquid Sunshine Instant Win and Sweepstakes
3. Dr Nabil Dib Takes on Special Advisor Role to the Stemedica Board of Directors
4. As New Administration Takes Office, Deloitte Report Identifies $530 Billion Savings Opportunity for Health Care Reform Over Next 10 Years
5. In High-Stakes Stock Trading, Finger Length Matters
6. Kimberly-Clark and ABCs The View Award $400,000 for Room Makeovers in the Room-A-Day Giveaway Sweepstakes
7. BioFit 1Y Takes the Plunge to Fill Undersea Seating Role for NOAA
8. U.S. Continues to Lag Behind European Countries in Teen Sexual Health - Cleveland Sex Ed Initiative Takes Promising Science-Based Approach
9. New drug development still takes 8 years despite faster FDA review, according to Tufts CSDD
10. Economic Downturn Takes Toll on California Hospitals
11. It takes 2 to know 1: Shared experiences change self-recognition